Cargando…
Beyond a single pathway: combination therapy in pulmonary arterial hypertension
There is a strong rationale for combining therapies to simultaneously target three of the key pathways implicated in the pathogenesis of pulmonary arterial hypertension (PAH). Evidence to support this strategy is growing, and a number of studies have demonstrated that combination therapy, administer...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487558/ https://www.ncbi.nlm.nih.gov/pubmed/27903663 http://dx.doi.org/10.1183/16000617.0085-2016 |